开云app官网登录入口网页版-官方正版

#替卡格雷#

39篇内容 | 1575人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1370716, encodeId=204d13e071690, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=Stroke：高血压对替卡格雷-阿司匹林与氯吡格雷-阿司匹林治疗卒中效果的影响, objectType=article, longId=729042, objectId=e522e2904223, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e522e2904223, replyNumber=0, likeNumber=57, createdTime=2022-06-11, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e522e2904223, moduleTitle=Stroke：高血压对替卡格雷-阿司匹林与氯吡格雷-阿司匹林治疗卒中效果的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e522e2904223)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370715, encodeId=71be13e071560, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=JAMA Neurology-天坛医院新发现：中度缺血性卒中，替卡格雷尔和阿司匹林联用，和单用阿司匹林效果无差异, objectType=article, longId=214666, objectId=6a8b2146668b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a8b2146668b, replyNumber=0, likeNumber=56, createdTime=2021-07-24, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a8b2146668b, moduleTitle=JAMA Neurology-天坛医院新发现：中度缺血性卒中，替卡格雷尔和阿司匹林联用，和单用阿司匹林效果无差异, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6a8b2146668b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370714, encodeId=e09913e071478, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=JAHA：替卡格雷治疗后大出血相关的因素分析, objectType=article, longId=208741, objectId=9566208e4136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9566208e4136, replyNumber=0, likeNumber=68, createdTime=2021-03-21, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9566208e4136, moduleTitle=JAHA：替卡格雷治疗后大出血相关的因素分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9566208e4136)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370713, encodeId=8c1713e07130c, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=JAMA：替卡格雷vs氯吡格雷对PCI后急性冠状动脉综合征患者净不良临床事件风险的影响, objectType=article, longId=202586, objectId=ddad2025866b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddad2025866b, replyNumber=0, likeNumber=82, createdTime=2020-10-30, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddad2025866b, moduleTitle=JAMA：替卡格雷vs氯吡格雷对PCI后急性冠状动脉综合征患者净不良临床事件风险的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ddad2025866b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370712, encodeId=eb8613e0712d8, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=JACC：单用替卡格雷对伴有糖尿病PCI患者的影响, objectType=article, longId=194338, objectId=337a19433873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=337a19433873, replyNumber=0, likeNumber=103, createdTime=2020-05-20, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=337a19433873, moduleTitle=JACC：单用替卡格雷对伴有糖尿病PCI患者的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=337a19433873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370711, encodeId=d86f13e0711ec, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=JACC：接受PCI的高危糖尿病患者采用替卡格雷治疗加或不加阿司匹林疗效比较, objectType=article, longId=191250, objectId=3a751912507c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a751912507c, replyNumber=0, likeNumber=74, createdTime=2020-04-04, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a751912507c, moduleTitle=JACC：接受PCI的高危糖尿病患者采用替卡格雷治疗加或不加阿司匹林疗效比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3a751912507c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370710, encodeId=0d5b13e07107e, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=JAMA Intern Med：PCI后ACS患者主要冠状动脉不良事件的预防——替卡格雷vs氯吡格雷, objectType=article, longId=186599, objectId=149a186599e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=149a186599e2, replyNumber=0, likeNumber=80, createdTime=2020-01-22, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=149a186599e2, moduleTitle=JAMA Intern Med：PCI后ACS患者主要冠状动脉不良事件的预防——替卡格雷vs氯吡格雷, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=149a186599e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370709, encodeId=6fc713e07091a, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=Eur Heart J：既往有心肌梗塞且无冠状动脉支架置入的患者长期服用替卡格雷进行二级预防, objectType=article, longId=184454, objectId=f5c518445459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5c518445459, replyNumber=0, likeNumber=65, createdTime=2019-12-10, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5c518445459, moduleTitle=Eur Heart J：既往有心肌梗塞且无冠状动脉支架置入的患者长期服用替卡格雷进行二级预防, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f5c518445459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370708, encodeId=c54113e070828, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=NEJM：PCI术后高危患者服用替卡格雷加不加阿司匹林？, objectType=article, longId=183360, objectId=6175183360f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6175183360f1, replyNumber=0, likeNumber=68, createdTime=2019-11-23, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6175183360f1, moduleTitle=NEJM：PCI术后高危患者服用替卡格雷加不加阿司匹林？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6175183360f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370707, encodeId=ab5813e070715, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=JACC：PCI术后替卡格雷和双重抗凝治疗的比较, objectType=article, longId=182185, objectId=17ea182185cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ea182185cb, replyNumber=0, likeNumber=68, createdTime=2019-11-01, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ea182185cb, moduleTitle=JACC：PCI术后替卡格雷和双重抗凝治疗的比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=17ea182185cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370706, encodeId=4b5f13e0706c8, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=NEJM：急性冠状动脉综合征患者替卡格雷或普拉格雷疗效比较, objectType=article, longId=181442, objectId=f4ee18144209, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4ee18144209, replyNumber=0, likeNumber=65, createdTime=2019-10-18, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4ee18144209, moduleTitle=NEJM：急性冠状动脉综合征患者替卡格雷或普拉格雷疗效比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f4ee18144209)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370705, encodeId=e23513e070508, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=NEJM：替卡格雷用于稳定型冠心病和糖尿病患者疗效, objectType=article, longId=180466, objectId=f21018046671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f21018046671, replyNumber=0, likeNumber=70, createdTime=2019-10-05, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f21018046671, moduleTitle=NEJM：替卡格雷用于稳定型冠心病和糖尿病患者疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f21018046671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370704, encodeId=dbce13e070434, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=替卡格雷联合阿司匹林显著降低冠心病和2型糖尿病患者的心血管事件风险, objectType=article, longId=178639, objectId=33d51e8639b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33d51e8639b9, replyNumber=0, likeNumber=60, createdTime=2019-09-04, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33d51e8639b9, moduleTitle=替卡格雷联合阿司匹林显著降低冠心病和2型糖尿病患者的心血管事件风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=33d51e8639b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370703, encodeId=326713e070347, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=BMJ：替卡格雷对轻度中风或短暂性缺血血小板反应性的影响, objectType=article, longId=168673, objectId=3f991686e387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f991686e387, replyNumber=0, likeNumber=57, createdTime=2019-06-19, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f991686e387, moduleTitle=BMJ：替卡格雷对轻度中风或短暂性缺血血小板反应性的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3f991686e387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370702, encodeId=49f413e070237, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=NEJM：基于抗体的替卡格雷逆转剂效果分析, objectType=article, longId=165753, objectId=ec5b165e53d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec5b165e53d4, replyNumber=0, likeNumber=75, createdTime=2019-05-10, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec5b165e53d4, moduleTitle=NEJM：基于抗体的替卡格雷逆转剂效果分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ec5b165e53d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370701, encodeId=859813e070119, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=逆转替卡格雷的抗血小板作用：PB2452的I期临床试验的全部结果现已公布, objectType=article, longId=162732, objectId=e5cb162e32cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5cb162e32cd, replyNumber=0, likeNumber=66, createdTime=2019-03-23, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5cb162e32cd, moduleTitle=逆转替卡格雷的抗血小板作用：PB2452的I期临床试验的全部结果现已公布, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e5cb162e32cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370700, encodeId=dc7a13e0700dc, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=Stroke：心肌梗死后使用替卡格雷不会增加颅内出血的风险, objectType=article, longId=155909, objectId=d46f155909bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d46f155909bd, replyNumber=0, likeNumber=61, createdTime=2018-12-18, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d46f155909bd, moduleTitle=Stroke：心肌梗死后使用替卡格雷不会增加颅内出血的风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d46f155909bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370699, encodeId=9cd213e06993b, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=Stroke：心肌梗死后替卡格雷的使用增加与颅内出血无关, objectType=article, longId=152765, objectId=bd28152e65ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd28152e65ae, replyNumber=0, likeNumber=59, createdTime=2018-11-06, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd28152e65ae, moduleTitle=Stroke：心肌梗死后替卡格雷的使用增加与颅内出血无关, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=bd28152e65ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370698, encodeId=813713e069886, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=Lancet：替卡格雷联合阿司匹林用于PCI后抗血小板治疗的效果不优于标准方案, objectType=article, longId=147564, objectId=3d3514e56477, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d3514e56477, replyNumber=0, likeNumber=68, createdTime=2018-08-30, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d3514e56477, moduleTitle=Lancet：替卡格雷联合阿司匹林用于PCI后抗血小板治疗的效果不优于标准方案, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3d3514e56477)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1370697, encodeId=2f5a13e069728, content=<a href='/topic/show?id=691a603409f' target=_blank style='color:#2F92EE;'>#替卡格雷#</a>, objectTitle=JAHA：替卡格雷在急性心肌梗死中的应用！, objectType=article, longId=140473, objectId=18d31404e386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18d31404e386, replyNumber=0, likeNumber=54, createdTime=2018-06-12, rootId=0, userName=lifangping, userId=2fe4321, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18d31404e386, moduleTitle=JAHA：替卡格雷在急性心肌梗死中的应用！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=18d31404e386)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

替卡格雷

2020-05-29

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

Stroke：高血压对替卡格雷-阿司匹林与氯吡格雷-阿司匹林治疗卒中效果的影响

2022-06-11

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

JAMA Neurology-天坛医院新发现：中度缺血性卒中，替卡格雷尔和阿司匹林联用，和单用阿司匹林效果无差异

2021-07-24

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

JAHA：替卡格雷治疗后大出血相关的因素分析

2021-03-21

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

JAMA：替卡格雷vs氯吡格雷对PCI后急性冠状动脉综合征患者净不良临床事件风险的影响

2020-10-30

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

JACC：单用替卡格雷对伴有糖尿病PCI患者的影响

2020-05-20

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

JACC：接受PCI的高危糖尿病患者采用替卡格雷治疗加或不加阿司匹林疗效比较

2020-04-04

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

JAMA Intern Med：PCI后ACS患者主要冠状动脉不良事件的预防——替卡格雷vs氯吡格雷

2020-01-22

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

Eur Heart J：既往有心肌梗塞且无冠状动脉支架置入的患者长期服用替卡格雷进行二级预防

2019-12-10

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

NEJM：PCI术后高危患者服用替卡格雷加不加阿司匹林？

2019-11-23

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

JACC：PCI术后替卡格雷和双重抗凝治疗的比较

2019-11-01

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

NEJM：急性冠状动脉综合征患者替卡格雷或普拉格雷疗效比较

2019-10-18

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

NEJM：替卡格雷用于稳定型冠心病和糖尿病患者疗效

2019-10-05

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

替卡格雷联合阿司匹林显著降低冠心病和2型糖尿病患者的心血管事件风险

2019-09-04

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

BMJ：替卡格雷对轻度中风或短暂性缺血血小板反应性的影响

2019-06-19

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

NEJM：基于抗体的替卡格雷逆转剂效果分析

2019-05-10

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

逆转替卡格雷的抗血小板作用：PB2452的I期临床试验的全部结果现已公布

2019-03-23

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

Stroke：心肌梗死后使用替卡格雷不会增加颅内出血的风险

2018-12-18

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

Stroke：心肌梗死后替卡格雷的使用增加与颅内出血无关

2018-11-06

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

Lancet：替卡格雷联合阿司匹林用于PCI后抗血小板治疗的效果不优于标准方案

2018-08-30

lifangping (审核中...)

前往app查看评论内容

#替卡格雷#

JAHA：替卡格雷在急性心肌梗死中的应用！

2018-06-12

科室
- - 订阅+
  - 更多科室
工具
服务